europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

EuropaBio Response to the publication of the Bioeconomy Strategy Progress Report

09/06/2022
PRESS RELEASE
Response to the publication of the Bioeconomy Strategy Progress Report: industrial biotechnology as one of the key drivers towards a more sustainable Europe

Brussels, 9 June 2022 – EuropaBio welcomes the progress report on the 2018 EU Bioeconomy Strategy, marking ten years since the first EU strategy published in 2012. It is crucial to take stock of progress made and identify critical future developments to further advance the implementation of the EU Bioeconomy Strategy.

Beyond assessing the implementation of the 2018 updated Strategy and advances throughout Europe, the progress report frames the increasing importance of the bioeconomy in the current EU policy context. Indeed, when it comes to advancing progress towards EU Green Deal objectives, alternatives to fossil-based products, improved resource efficiency of industrial processes and innovative food and feed are all targets where bioeconomy innovation can deliver.

Claire Skentelbery, Director General of EuropaBio, commented, ‘Industrial biotechnology drives the bioeconomy, using biological systems across sectors and applications to transform products and processes away from petro-chemicals. Europe in particular has a very strong focus on the green transition which means that the role of biotechnology will continue to grow and we will see an increasing number of products on the market that contribute to building a more sustainable European society’.

An innovation-driven circular bioeconomy, with increased sustainability as its end goal, also meets industrial priorities to deliver efficiency, competitiveness and employment. It must increasingly move to large scale biological manufacturing systems across sectors, integrated into the process industry, manufacturing and recycling. In addition to taking stock of the actions set out in the 2018 Bioeconomy Strategy, it is crucial to also consider the bioeconomy in the implementation of other EU Green Deal policies and initiatives.

EuropaBio Response to the publication of the Bioeconomy Strategy Progress Report


Download
2022_06_I_PR_EuropaBio-Response-to-Bioeconomy-Strategy-Progress-ReportDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

17/01/2023

EuropaBio launches SME BioForum in Rare Diseases


Read more
17/01/2023

EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform


Read more
16/01/2023

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins


Read more
19/12/2022

EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe


Read more

Important links

  • EuropaBio launches SME BioForum in Rare Diseases
  • EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform

Categories in our Newsroom

Search by tags

  • Innovation
  • Excellence
  • Science
  • ATMPs
  • Healthcare Biotech
  • Industrial Biotech
  • Investment
  • EuropaBio
  • EFIB
  • Regulation
  • Rare Diseases
  • COVID-19
  • Members
  • Cancer
  • Patients
  • Patient BioForum
  • Gene & Cell Therapies
  • Accessibility
  • Intellectual Property
  • Pharmaceutical Strategy for Europe

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member